Phase 3 Parkinson Disease Clinical Trials
12 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–12 of 12 trials
Recruiting
Phase 2Phase 3
Montelukast in Parkinson Disease
Parkinson Disease
Mostafa Bahaa60 enrolled1 locationNCT06113640
Recruiting
Phase 3
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
PARKINSON DISEASE (Disorder)
University Hospital Tuebingen150 enrolled3 locationsNCT07151378
Recruiting
Phase 3
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
Parkinson's Disease (PD)Freezing of GaitFreezing of Gait Symptoms in Parkinson Disease
Radboud University Medical Center60 enrolled1 locationNCT07316296
Recruiting
Phase 3
18F-DOPA II - PET Imaging Optimization
Neuroendocrine TumorsBrain TumorNeuroblastoma+3 more
University of Alberta800 enrolled1 locationNCT04706910
Recruiting
Phase 2Phase 3
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Parkinson Disease
Tanta University46 enrolled1 locationNCT06785298
Recruiting
Phase 2Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Parkinson Disease
Biohaven Therapeutics Ltd.550 enrolled15 locationsNCT06976268
Recruiting
Phase 3
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Parkinson Disease
Cerevance330 enrolled49 locationsNCT06553027
Recruiting
Phase 2Phase 3
Vinpocetine in Patients With Parkinsonian Disease
Parkinson Disease
Tanta University60 enrolled1 locationNCT07229664
Recruiting
Phase 2Phase 3
Metformin in Parkinson Disease
Parkinson Disease
Tanta University60 enrolled1 locationNCT07229651
Recruiting
Phase 3
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
Parkinson DiseaseDysphagia
Northwestern University60 enrolled1 locationNCT04664634
Recruiting
Phase 3
Ambroxol to Slow Progression in Parkinson Disease
Parkinson Disease
University College, London330 enrolled15 locationsNCT05778617
Recruiting
Phase 2Phase 3
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
Alzheimer DiseaseParkinson DiseaseDementia With Lewy Bodies+1 more
prof. dr. Koen Van Laere113 enrolled2 locationsNCT06120049